Professor Jing Cheng Wins the 2008 HO LEUNG HO LEE Prize for Youth Innovation

October 29^th, 2008, Professor Jing Cheng, the Director of NERCBBT (National Engineering Research Center for Beijing Biochip Technology) and the CTO of CapitalBio Corporation has been awarded the "2008 HOLEUNG HO LEE Prize for Youth Innovation" for his outstanding contribution to the development of Biochip Technology in China. 

The Ho Leung Ho Lee (HLHL) Foundation was established in 1994 with the donation of Mr. Ho Sin-Hang, Mr. Leung Kau-Kui, Mr. Ho Tim and Mr. Lee Guo-Wei. The purpose of the foundation is to reward excellence in Chinese scholarship in the scientific and medical fields, to encourage respect for knowledge and motivate talented people, and to foment scientific research through the encouragement of scientific and technological workers. The Ho Leung Ho Lee Foundation is the largest private scientific and technological foundation in China. The "The HLHL Prize" is awarded annually and consists of three parts, "the HLHL Scientific and Technological Achievement Prize", "the HLHL Scientific and Technological Progress Prize" and "the HLHL Scientific and Technological Innovations Prize". "The HLHL Scientific and Technological Innovations Prize" is the most recent, being instigated in 2006, and consists of three sub-prizes, the "Prize for Youth Innovation", the "Prize for Industry Innovation" and the "Prize for Regional Innovation". The selection of candidates of "Prize for Youth Innovation" focuses on China`s young scientific and technical workers who have significant achievements in their research fields and are younger than 45 years old.

Professor Cheng has rigorous scholarship and is extremely creative. After returning to China in 1999 from a senior position within an American biochip company, he devoted himself to the R&D and commercialization of the various types of biochips and related microarray equipment. He directed the research and development of more than 50 different biochip products for clinical testing, food safety analysis and drug discovery, lab-on-a-chips, and numerous life science related instruments, including a series of confocal laser microarray scanners and CCD-based scanners, a microarray hybridization incubator and a microarray wash station and a series of dual delivery microarray spotters, as well as numerous active biochips including a electronic rotary cell vitality detection chip and cell migration assay chips. Some of these products have been exported to a number of countries, including Germany, Britain, Sweden, Italy, Finland, Spain, Portugal, Austria, Switzerland, Denmark, Lebanon, and the United States. CapitalBio has had a total of nearly 200 million RMB yuan in sales income from China and overseas, and has provided thousands of high quality microarray services to Universities and research institutes. Professor Cheng has produced over 90 peer reviewed papers, edited eight books and published more than 20 domestic and international patents and won the second place of the 2007 State Scientific & Technological Award. Professor Cheng has played a central role in technological innovation, international image promotion and the creation of China`s biochip industry.